Forget password

We use cookies to help us improve, promote and protect our services. By continuing to use the site, you agree to ourcookie policy

Join

2021 TMUxBE比翼與北醫生醫加速器計畫Demo Day 加速醫院決策通道,為新創取得更多臨床導入機會

CategoryNews

Lecture Date:

2021-07-26

REGISTRATION EVENT

HOME Our Program

2021 TMUxBE比翼與北醫生醫加速器計畫Demo Day 加速醫院決策通道,為新創取得更多臨床導入機會

2021-07-26
ECDFCE21-AE45-447E-B712-742F356D52DA (2)
2021 TMUxBE比翼與北醫生醫加速器計畫Demo Day
加速醫院決策通道,為新創取得更多臨床導入機會
Meet the startups that Participated in TMU x BE’s Latest demo day in Taiwan

TMUxBE比翼與北醫生醫加速器計畫為台灣首創 「醫院」聯合「創投」 專注於 「智慧醫療」 的新創輔導計畫 ,今 (7/20),舉辦2021年度新一期輔導成果展,並且此次Demo Day邀請到科技部許增如司⻑為我們致詞,9組生醫新創陸續登台,領域橫跨AI疾病預測、AI智慧共聘、智能穿戴裝置、大數據分析平台、腹膜透析平台、肺部疾病照護、生技分析試劑。

At Taiwan-based TMU x BE accelerator’s demo day on July 20, startups discussed their solutions, which tackle topics like Digital Health, Medical Devices and AI Healthcare.

延續2020年啟動的雙強聯手加速計劃(即TMUxBE生醫加速計畫),今年度除了持續導入臺北醫學大學「1校6院」臨床資源,比翼與北醫在輔導期間更組成了「三院諮議委員會」,即邀請北醫附設醫院、萬芳醫院和雙和醫院三院主任級以上決策層,面對面與生醫新創提出之商業合作計劃進行討論,從體制內加速醫院決策與評估流程,創造更多新創臨床合作機會。

 A series of startups told their stories as part of TMU x BE Accelerator’s demo day.

本次活動也是第一次挑戰全程於攝影棚直播,9組新創透過攝影直播進行五分鐘簡報以及臨場QA問答,面對無實體觀眾的舞台依然能抓緊節奏,分享經歷五個多月輔導加強,注入眾多專業的生醫資源下,如何加速商業成長。

Further, TMU BioMed Accelerator is Taiwan's first international medical university accelerator with a perfect medical marketplace, clinical advantages, biomedical and AI talents, focusing on digital health, artificial intelligence and medical equipment.

本次活動中除展現輔導實績外,也分享即將推出的「海外示範擴張計劃」(Market Expansion Pilot Trial),邀請到美國合作夥伴Christine Winoto, Executive Director of UCSF Rosenman Institute,以及日本合作夥伴Yujiro Maeda, Co-director of Japan Biodesign & Co-founder of Premo Partner,相信對台灣醫療新創團隊的海外擴展會有極大的幫助!

And BE Accelerator is the largest growth-focused program and venture fund for healthtech, medtech and digital health startups in Taiwan. Started in 2018, BE backed fifty-one healthcare entrepreneurs, and raise $75.8M+ USD successfully.
Last but not least, TMU BioMed and BE accelerator’s 2021 Market Expansion Pilot Trial allows startups to expand in American and Japanese markets to activate their growth after the demo day.




九家新創公司簡介:
ATGENOMIX 亞大基因科技股份有限公司, Taiwan
亞大基因科技是具多重優勢的基因定序檢測Bio-IT平台軟體公司,致力於發展創新的基因體大數據分析工作流程。希望運用精準醫療,讓每個人都能根據個體基因的獨特差異,得到最適合的個人化醫療服務。

With a team of data scientists with a single-minded focus on driving innovative computing in clinical genomics, Atgenomix accelerates future life science and helps overwhelmed researchers and clinicians deal with the immense challenges of data deluge in genomics.

Big Data Mobile company 巨量移動科技股份有限公司, Taiwan
B.D. Mobile是一家以AI與生醫感測演算為核心技術的數位醫療科技公司,公司專注於心血管疾病篩選與判讀的相關產品開發。所研發的「AI-Screening」判讀生醫系統,可加速獲得心血管疾病的特徵標記,輔助醫生病人取得全身心血管熱點分析報告。

B.D.Mobile is a medical technology company committed to making cardiac diagnostics scalable and accessible to everyone, by creating solutions for clinicians to face the ever-increasing demand for diagnostics.

Genius Holdings Co., Ltd.薩摩亞商傑尼斯投資控股有限公司台灣分公司, Taiwan
傑尼斯以研發與技術導向,專注於呼吸領域照護與聲音人工智慧相關應用的IoT與IoMT設備。公司擁有超聲檢測氣體流速之多國發明專利,以及聲音AI演算法技術,並已實現於肺功能儀等多項醫療器械產品中。

ezOxygen Spirometer utilizes exclusive passive ultrasonic detection technology to record the sound from the user’s exhalation, transmit to the mobile app and calculate as lung function parameters, provide user managing their own lung health status.

HOME心梁山股份有限公司, Taiwan
HOME心是衛福部指定合作的新創公司,共同推動智慧共聘,利用智慧平台劃分出重點照顧項目,再運用AI配對模型用最短的時間配對最適合的照服員,為生病住院的家庭提供最適合的照顧服務。

Focuses on long-term healthcare, HomeXin provides hospitalized families comprehensive help services.

LuminX Biotech Co. Ltd路明思生技股份有限公司, Taiwan
路明思生技為細胞GPS定位與定量分析的專家,核心技術為「LuminX螢光奈米鑽石標靶」技術,注入生物體後,可長時間準確地追縱細胞的定位與定量,建立體內生物分佈分析、細胞藥物動力學與藥理分析平台,加速細胞療法產品開發,幫助細胞相關產品進入臨床試驗階段。

Based in Taiwan, LuminX is a pharmacokinetic platform for preclinical evaluation of therapeutic cells to transform a potential therapy from the research stage to advanced clinical and commercial applications to save lives.

MERACLE PTE LTE, Singapore
MERACLE研發的Whizz,透過提高肺部藥物的吸入效率和紀錄藥物攝入量數據,改善對吸入性藥物治療的評估,從而改善慢性呼吸系統疾病的管理。

Based in Singapore, Meracle wants to improve the management of chronic respiratory diseases by increasing the efficiency of medication delivered into the lungs while tracking intake data to optimize the assessment of treatment outcomes

PROPHET.CARE 早覺醫學, Taiwan
PROPHET.CARE於2020年成立,產品經過十年以上國內醫療大數據研發,不須侵入式檢查、僅需過去的病史資料即可進行疾病預測,透過AI人工智慧技術提早鎖定狙擊,進行疾病精準預防,把握治療時機。

PROPHET, an AI Bio-maker model using AI technology to screen cancer and provide the prediction.

SIRIUXENSE澔心科技股份有限公司, Taiwan
澔心科技首推的胎兒智能照護穿戴裝置,如同智慧手錶般穿戴於孕婦肚上;毋須專業人員操作即可聆聽胎心音、計算胎動和偵測母親心率,為孕婦提供超過2個小時的連續胎兒監護儀,融合感測技術搭配演算法,搭載於物聯網穿戴裝置之上,作為孕期在家胎兒照護。

SiriuXense builds the “Smart Care Ecosystem for All Ages'' by integrating bioacoustics sensing technology, algorithm, IoT, and a data-driven platform.

UpperMed PTE.LTD 雅渼生醫股份有限公司, Singapore
UpperMed為家用洗腎遠端管理平台,結合可攜帶裝置及搭配使用的app服務,希望縮短腎友腹膜透析換液所需的一半時間,並在過程中自動紀錄透析液各項數據,後續可透過APP追蹤,也便於病患與醫生進行溝通。

UpperMed, a Singapore-based MedTech company which is working on home dialysis remote management service. The team is dedicated to improving the quality of life for dialysis patients.

主辦單位介紹:
比翼加速器
以生技醫療照護為關注重點的比翼加速器(BE Accelerator),同時也是台灣最大的醫療生技新創加速器,以長期關注醫療相關為主軸,透過與全球多家重量級醫療院所的合作關係,積極投入資源於生物科技與醫療照護領域的新創團隊,以拓展亞洲及歐美市場。從 2018 年成立之際,至今已孵化五十一組團隊,募資總金額高達 75.8M 美金。

[About BE Accelerator]
BE Accelerator is the largest growth-focused program and venture fund for healthtech, medtech and digital health startups in Taiwan. Based in Taipei, we leverage the unique strengths of our thriving ecosystem to position as the gateway to Asia for both local and international startups. Started in 2018, we back fifty-one healthcare entrepreneurs, and raise $75.8M+ USD successfully.

北醫生醫加速器
臺灣首家國際級創新醫療大學加速器,擁有完善的醫療市場、臨床醫療優勢及生醫與人工智慧人才,並專注於「數位醫療」、「人工智慧」、與「醫療器材」三大主題,協助新創團隊創業資金募集、新創社群與國際資源的鏈結、輔導團隊技能與協助降低產品開發風險、與臨床試驗規劃並建立醫療通路,並善用北醫完善的醫療臨床場域與專業醫師,輔導新創團隊產品在臨床試驗的研發策略,使新創團隊加速研究成果商品化並鏈結國際生態圈。

[About BE Accelerator]
BE Accelerator is the largest growth-focused program and venture fund for healthtech, medtech and digital health startups in Taiwan. Based in Taipei, we leverage the unique strengths of our thriving ecosystem to position as the gateway to Asia for both local and international startups. Started in 2018, we back fifty-one healthcare entrepreneurs, and raise $75.8M+ USD successfully.
 
聯繫人:
比翼加速器
陳欣潔行銷經理 Polly Chen|0909-543-177|Polly@behealthventures.com

臺北醫學大學加速器
易詩恩副執行長 Sharon Yi |  0988-275812 | sharonyi@tmu.edu.tw
辜善揚專案副理 Sebastian Ku |  0980-663-773 | Sebastianku@tmu.edu.tw

Media Contact:
BE Accelerator, Polly Chen Polly@behealthventures.com

YOU MIGHT LIKE THESE ACTIVITIES

  • 2021-02-18

    TTA Black Card Membership Open for Application

    CategoryNews
    • #TTA
  • New
    2021-10-27

    TTA南部據點x 創新實證碰撞沙龍系列巡迴交流( III )~邀請你來交流!

    CategoryNews
    • #TTA
    • #TTA South
  • New
    2021-10-27

    TTA南部據點x 創新實證碰撞沙龍系列巡迴交流( II )~邀請你來交流!

    CategoryNews
    • #TTA
    • #TTA South